Monte Rosa Therapeutics, Inc. (GLUE)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-16 | Warmuth Markus | director | S | 9,500 | 23.18 | $220,219 |
| 2026-07-15 | Champoux Jennifer | officer | M | 4,351 | 3.98 | $17,317 |
| 2026-07-15 | Champoux Jennifer | officer | S | 4,351 | 23.38 | $101,730 |
| 2026-07-06 | Townson Sharon | officer | M | 6,000 | 6.14 | $36,840 |
| 2026-07-06 | Townson Sharon | officer | S | 5,600 | 23.25 | $130,197 |
| 2026-07-06 | Townson Sharon | officer | S | 400 | 24.13 | $9,652 |
| 2026-07-01 | Behbahani Ali | director | J | 1,000,000 | 0 | $0 |
| 2026-07-01 | Behbahani Ali | director | J | 15,000 | 0 | $0 |
| 2026-07-01 | Behbahani Ali | director | J | 15,000 | 0 | $0 |
| 2026-06-30 | Janku Filip | officer | M | 5,407 | 13.41 | $72,508 |
| 2026-06-30 | Janku Filip | officer | S | 5,407 | 24.5 | $132,472 |
| 2026-06-29 | Janku Filip | officer | M | 6,000 | 7.56 | $45,360 |
| 2026-06-29 | Janku Filip | officer | S | 6,000 | 22.95 | $137,700 |
| 2026-06-29 | Manning Anthony M. | director | M | 10,000 | 4.16 | $41,600 |
| 2026-06-29 | Manning Anthony M. | director | S | 10,000 | 23.11 | $231,100 |
| 2026-06-29 | Janku Filip | officer | M | 6,000 | 7.56 | $45,360 |
| 2026-06-29 | Janku Filip | officer | S | 6,000 | 22.95 | $137,700 |
| 2026-06-29 | Manning Anthony M. | director | M | 10,000 | 4.16 | $41,600 |
| 2026-06-29 | Manning Anthony M. | director | S | 10,000 | 23.11 | $231,100 |
| 2026-06-24 | Janku Filip | officer | S | 30,000 | 21.42 | $642,600 |
| 2026-06-24 | Janku Filip | officer | M | 30,000 | 7.56 | $226,800 |
| 2026-06-24 | Janku Filip | officer | M | 30,000 | 7.56 | $226,800 |
| 2026-06-24 | Janku Filip | officer | S | 30,000 | 21.42 | $642,681 |
| 2026-06-23 | Janku Filip | officer | S | 11,845 | 20.22 | $239,506 |
| 2026-06-23 | Janku Filip | officer | M | 6,000 | 7.56 | $45,360 |
| 2026-06-23 | Townson Sharon | officer | M | 3,000 | 6.14 | $18,420 |
| 2026-06-23 | Townson Sharon | officer | S | 3,000 | 20 | $60,000 |
| 2026-06-23 | Champoux Jennifer | officer | S | 2,175 | 20 | $43,500 |
| 2026-06-23 | Champoux Jennifer | officer | M | 2,175 | 3.98 | $8,657 |
| 2026-06-23 | Janku Filip | officer | M | 6,000 | 7.56 | $45,360 |
| 2026-06-23 | Janku Filip | officer | S | 11,845 | 20.22 | $239,522 |
| 2026-06-23 | Champoux Jennifer | officer | M | 2,175 | 3.98 | $8,657 |
| 2026-06-23 | Champoux Jennifer | officer | S | 2,175 | 20 | $43,500 |
| 2026-06-23 | Townson Sharon | officer | M | 3,000 | 6.14 | $18,420 |
| 2026-06-23 | Townson Sharon | officer | S | 3,000 | 20 | $60,000 |
| 2026-06-17 | Champoux Jennifer | officer | M | 2,176 | 3.98 | $8,660 |
| 2026-06-17 | Champoux Jennifer | officer | S | 2,176 | 19 | $41,344 |
| 2026-06-17 | Townson Sharon | officer | M | 3,000 | 6.14 | $18,420 |
| 2026-06-17 | Townson Sharon | officer | S | 3,000 | 19 | $57,000 |
| 2026-06-17 | Champoux Jennifer | officer | M | 2,176 | 3.98 | $8,660 |
| 2026-06-17 | Champoux Jennifer | officer | S | 2,176 | 19 | $41,344 |
| 2026-06-17 | Townson Sharon | officer | M | 3,000 | 6.14 | $18,420 |
| 2026-06-17 | Townson Sharon | officer | S | 3,000 | 19 | $57,000 |
| 2026-06-01 | Warmuth Markus | director | S | 4,998 | 19.41 | $97,011 |
| 2026-06-01 | Warmuth Markus | director | S | 468 | 19.73 | $9,234 |
| 2026-06-01 | Warmuth Markus | director | S | 4,998 | 19.41 | $97,021 |
| 2026-06-01 | Warmuth Markus | director | S | 468 | 19.73 | $9,232 |
| 2026-05-29 | Townson Sharon | officer | M | 6,000 | 6.14 | $36,840 |
| 2026-05-29 | Townson Sharon | officer | S | 6,000 | 19.87 | $119,220 |
| 2026-05-29 | Townson Sharon | officer | M | 6,000 | 6.14 | $36,840 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-08 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G
- 2026-08-06 10-Q
- 2026-08-06 8-K
- 2026-07-17 4
- 2026-07-16 4
- 2026-07-16 144
- 2026-07-15 144
- 2026-07-08 SCHEDULE 13G/A
- 2026-07-07 4
- 2026-07-06 4
- 2026-07-06 SCHEDULE 13D/A
- 2026-07-01 4
- 2026-06-30 144
- 2026-06-30 4
- 2026-06-30 4
- 2026-06-29 144
- 2026-06-29 144
- 2026-06-25 4